A randomized , single-blinded , placebo-controlled trial was performed on @ subjects : @ subjects received ATG ( @ mg/kg intravenously ) followed by pegylated G-CSF ( @ mg subcutaneously every @ weeks for @ doses ) and @ subjects received placebo .